Trade ELDN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Eledon Pharmaceuticals, Inc. (ELDN) is trading at US$3.20, down 3.61% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$280.35M. Over the past 52 weeks, ELDN has traded between US$1.35 and US$4.60. On Syfe you can trade ELDN with $0 commission and add it to your watchlist.
| Previous close | US$3.32 |
|---|---|
| Market cap | US$280.35M |
| 52-week range | US$1.35 – US$4.60 |
| Volume | 1.01M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in development of therapies to protect transplanted organs and prevent rejection. The firm also focuses on development of therapy to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L), a biological target with broad therapeutic potential. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.
Year: 2014
Eledon Says Mid-Stage Data Shows Tegoprubart Offers Higher Kidney Function, Improved Outcomes Compared with Tacrolimus
Jun 22, 12:20 PM · MT Newswires
Eledon Pharmaceuticals Files $500 Million Mixed Shelf Registration
May 1, 8:32 PM · MT Newswires
Eledon Pharmaceuticals Secures US FDA Orphan Drug Designation for Liver Transplant Rejection Treatment
Mar 10, 11:54 AM · MT Newswires
Eledon Pharmaceuticals, Inc. (ELDN) stock is trading at US$3.20, -3.61% from the previous close of US$3.32.
The market cap for Eledon Pharmaceuticals, Inc. (ELDN) stock is approximately US$280.35M.
The 52-week high for Eledon Pharmaceuticals, Inc. (ELDN) stock is US$4.60.
The 52-week low for Eledon Pharmaceuticals, Inc. (ELDN) stock is US$1.35.
Eledon Pharmaceuticals, Inc. (ELDN) does not currently pay a dividend.
Stay on top of ELDN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
